|
시장보고서
상품코드
1697136
세계의 임상시험 이미징 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)Clinical Trial Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032 |
||||||
세계의 임상시험 이미징 시장 규모는 2025년에 15억 달러, 2032년에는 25억 달러에 달할 것으로 예측되고 있습니다. 2025년-2032년 예측 기간에 연평균 복합 성장률(CAGR)은 7.5%를 나타낼 전망입니다.
임상시험 이미징은 신약, 치료제, 의료기기의 효능과 안전성을 평가하기 위한 임상시험에서 MRI, CT 스캔, PET 스캔, 초음파 등의 의료 이미징 기술을 사용하는 것을 말합니다. 이러한 이미지 양식은 연구자의 정확한 질병 진단, 치료 모니터링 및 바이오마커 식별에 도움이 됩니다. 제약 기업과 생명공학 기업은 규제 당국의 승인을 지원하고 의약품 개발 기간을 단축하기 위해 이미지 기반 증거에 대한 의존도를 높이고 있기 때문에 임상시험 이미지 수요가 증가하고 있습니다.
세계의 임상시험 이미징 시장은 임상 연구에서 고급 이미징 기술의 채택 확대와 같은 몇 가지 중요한 요인에 의해 견인되고 있습니다. 암, 심혈관 질환, 신경 질환 등의 만성 질환의 유병률의 상승이, 의약품 임상시험에 있어서의 화상 기반의 바이오마커 수요를 촉진하고 있습니다. 게다가 세계 임상시험 건수 증가와 이미징 엔드포인트에 대한 엄격한 규제 요건이 함께 시장 성장을 가속하고 있습니다. 인공지능(AI) 및 머신러닝(ML)과 이미징 기술의 통합의 진보는 이미지 분석의 정확성을 더욱 높여 임상시험의 성과를 향상시키고 있습니다.
큰 성장 기회에도 불구하고, 임상시험 이미징 시장은 이미지 모달리티와 인프라와 관련된 높은 비용과 같은 문제에 직면하고 있습니다. 또한 각 지역의 규제 준수의 복잡성도 시장 확대의 장벽이 되고 있습니다. 게다가 이미지 데이터의 해석과 분석에 숙련된 전문가가 부족하기 때문에 효율적인 임상시험의 실시가 과제가 되고 있습니다. 또한 임상시험 승인 지연과 임상시험시설별 영상 진단 프로토콜의 편차가 이 시장의 운영상의 복잡성에 박차를 가하고 있습니다.
임상시험 이미징 시장은 클라우드 기반 이미징 솔루션과 원격 모니터링 기술의 채택 증가로 큰 성장 기회를 제공합니다. AI를 탑재한 이미지 처리 소프트웨어의 개발은 실시간 데이터 처리를 강화하고 이미지 분석을 자동화하므로 인적 오류가 줄어들 것으로 기대됩니다. 또한 제약회사, 의약품개발업무수탁기관(CRO), 영상서비스 제공업체 간의 전략적 제휴에 의해 임상시험의 영상처리 워크플로우의 합리화가 진행될 것으로 예상됩니다. 신흥 시장, 특히 아시아태평양에서의 임상시험의 확대는 시장 선수들에게 유리한 성장 전망을 제공합니다.
본 보고서에서는 세계의 임상시험 이미징 시장에 대해 조사했으며, 제품 및 서비스별, 모달리티별, 치료분야별, 최종사용자별, 지역별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.
목차
제1장 주요 요약
제2장 시장 개요
- 시장의 범위와 정의
- 시장 역학
- 거시경제 요인
- COVID-19의 영향 분석
- 예측 요인- 관련성과 영향
제3장 부가가치 통찰
제4장 가격 동향 분석, 2019년-2032년
제5장 세계의 임상시험 이미징 시장 전망
- 주요 하이라이트
- 시장 규모의 분석과 예측
- 과거 시장 규모 분석, 2019년-2024년
- 현재 시장 규모 분석과 예측, 2025년-2032년
- 세계의 임상시험 이미징 시장 전망 : 제품 및 서비스별
- 소개, 주요 조사 결과
- 과거 시장 규모와 수량(단위) 분석, 제품 및 서비스별, 2019년-2024년
- 현재 시장 규모와 수량(단위) 분석과 예측, 제품 및 서비스별, 2025년-2032년
- 시장의 매력 분석 : 제품 및 서비스별
- 세계의 임상시험 이미징 시장 전망 : 모달리티별
- 소개, 주요 조사 결과
- 과거 시장 규모 분석, 모달리티별, 2019년-2024년
- 현재 시장 규모 분석과 예측, 모달리티별, 2025년-2032년
- 시장의 매력 분석 : 모달리티별
- 세계의 임상시험 이미징 시장 전망 : 치료 분야별
- 소개, 주요 조사 결과
- 과거 시장 규모 분석, 치료 분야별, 2019년-2024년
- 현재 시장 규모 분석과 예측, 치료 분야별, 2025년-2032년
- 시장의 매력 분석 : 치료 영역
- 세계의 임상시험 이미징 시장 전망 : 최종 사용자별
- 소개, 주요 조사 결과
- 과거 시장 규모와 수량(단위) 분석, 최종 사용자별, 2019년-2024년
- 현재 시장 규모와 수량(단위) 분석과 예측, 최종 사용자별, 2025년-2032년
제6장 세계의 임상시험 화상 시장 전망 : 지역별
- 주요 하이라이트
- 과거 시장 규모와 수량(단위) 분석, 지역별, 2019년-2024년
- 현재 시장 규모와 수량(단위) 분석과 예측, 지역별, 2025년-2032년
- 북미
- 유럽
- 동아시아
- 남아시아와 오세아니아
- 라틴아메리카
- 중동 및 아프리카
- 시장의 매력 분석 : 지역별
제7장 북미의 임상시험 이미징 시장 전망
제8장 유럽의 임상시험 이미징 시장 전망
제9장 동아시아의 임상시험 이미징 시장 전망
제10장 남아시아 및 오세아니아의 임상시험 이미징 시장 전망
제11장 라틴아메리카의 임상시험 이미징 시장 전망
제12장 중동 및 아프리카의 임상시험 이미징 시장 전망
제13장 경쟁 구도
- 시장 점유율 분석, 2025년
- 시장 구조
- 기업 프로파일(상세 - 개요, 재무, 전략, 최근 동향)
- Ixico PLC
- Navitas Life Sciences
- Resonance Health
- Radiant Sage LLC
- Medpace
- WCG Clinical
- Icon PLC
- Voiant
- Clario
- Parexel International Corporation
- Anagram
- Calyx
- Invicro
제14장 부록
SHW 25.04.15Persistence Market Research has recently released a comprehensive report on the worldwide market for clinical trial imaging. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global clinical trial imaging market from 2025 to 2032.
Key Insights:
- Clinical Trial Imaging Market Size (2025E): US$ 1.5 Bn
- Projected Market Value (2032F): US$ 2.5 Bn
- Global Market Growth Rate (CAGR 2025 to 2032): 7.5%
Clinical Trial Imaging Market - Report Scope:
Clinical trial imaging refers to the use of medical imaging techniques such as MRI, CT scans, PET scans, and ultrasound in clinical trials to assess the efficacy and safety of new drugs, treatments, and medical devices. These imaging modalities help researchers in accurate disease diagnosis, treatment monitoring, and biomarker identification. The demand for clinical trial imaging is rising as pharmaceutical and biotechnology companies increasingly rely on imaging-based evidence to support regulatory approvals and accelerate drug development timelines.
Market Growth Drivers:
The global clinical trial imaging market is driven by several key factors, including the growing adoption of advanced imaging technologies in clinical research. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has fueled the demand for imaging-based biomarkers in drug trials. Moreover, the rising number of clinical trials globally, coupled with stringent regulatory requirements for imaging endpoints, is propelling market growth. Advancements in artificial intelligence (AI) and machine learning (ML) integration with imaging technologies are further enhancing image analysis accuracy, thus improving clinical trial outcomes.
Market Restraints:
Despite significant growth opportunities, the clinical trial imaging market faces challenges such as high costs associated with imaging modalities and infrastructure. The complexity of regulatory compliance in different regions also acts as a barrier to market expansion. Additionally, the shortage of skilled professionals for imaging data interpretation and analysis poses a challenge for efficient clinical trial execution. Delays in trial approvals and the variability in imaging protocols across different study sites further add to the operational complexities of this market.
Market Opportunities:
The clinical trial imaging market presents substantial growth opportunities driven by the increasing adoption of cloud-based imaging solutions and remote monitoring technologies. The development of AI-powered imaging software is expected to enhance real-time data processing and automate image analysis, reducing human errors. Additionally, strategic collaborations between pharmaceutical companies, contract research organizations (CROs), and imaging service providers are expected to streamline clinical trial imaging workflows. The expansion of clinical trials in emerging markets, particularly in Asia-Pacific, offers lucrative growth prospects for market players.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the clinical trial imaging market globally?
- How does the integration of AI and machine learning enhance imaging capabilities in clinical trials?
- Which therapeutic areas are leading in the adoption of clinical trial imaging solutions?
- Who are the key players in the clinical trial imaging market, and what strategies are they employing to gain a competitive advantage?
- What are the emerging trends and future growth prospects in the global clinical trial imaging market?
Competitive Intelligence and Business Strategy:
Leading players in the global clinical trial imaging market, including BioTelemetry, Parexel International Corporation, ICON plc, Medpace, and Biomedical Systems, focus on technological innovations, strategic partnerships, and service expansion to strengthen their market presence. Companies are investing in AI-driven imaging analysis platforms and cloud-based imaging solutions to improve clinical trial efficiency. Collaborations with pharmaceutical firms and CROs are facilitating the seamless integration of imaging endpoints in drug development studies. The increasing adoption of decentralized trials and remote imaging solutions is also shaping the future of clinical trial imaging, ensuring faster and more cost-effective trial execution.
Key Companies Profiled:
- Ixico PLC
- Navitas Life Sciences
- Resonance Health
- Radiant Sage LLC
- Medpace
- WCG Clinical
- Icon PLC
- Voiant
- Clario
- Parexel International Corporation
- Anagram
- Calyx
- Invicro
Clinical Trial Imaging Market Segmentation
By Product & Services
- Services
- Software
By Modality
- CT scan
- MRI
- X-Ray
- Ultrasound
By Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Orthopedics
- Obstetrics & Gynecology
By End User
- Contract Research Organizations (CROs)
- Pharmaceutical & Biotechnology Companies
- Academic and Government Research Institutes
By Region
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global Clinical Trial Imaging Market Snapshot, 2025-2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
- 3.1. Product & Services Adoption Analysis
- 3.2. Regulatory Landscape
- 3.3. Value Chain Analysis
- 3.4. Key Deals and Mergers
- 3.5. PESTLE Analysis
- 3.6. Porter's Five Force Analysis
4. Price Trend Analysis, 2019-2032
- 4.1. Key Highlights
- 4.2. Key Factors Impacting Product & Services Prices
- 4.3. Pricing Analysis By Product & Services
- 4.4. Regional Prices and Product & Services Preferences
5. Global Clinical Trial Imaging Market Outlook:
- 5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
- 5.2. Market Size (US$ Bn) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
- 5.3. Global Clinical Trial Imaging Market Outlook: Product & Services
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product & Services, 2019-2024
- 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
- 5.3.3.1. Services
- 5.3.3.2. Software
- 5.4. Market Attractiveness Analysis: Product & Services
- 5.5. Global Clinical Trial Imaging Market Outlook: Modality
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2024
- 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
- 5.5.3.1. CT scan
- 5.5.3.2. MRI
- 5.5.3.3. X-Ray
- 5.6. Market Attractiveness Analysis: Modality
- 5.7. Global Clinical Trial Imaging Market Outlook: Therapeutic Area
- 5.7.1. Introduction / Key Findings
- 5.7.2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Area, 2019-2024
- 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
- 5.7.3.1. Oncology
- 5.7.3.2. Neurology
- 5.7.3.3. Cardiology
- 5.7.3.4. Orthopedics
- 5.7.3.5. Obstetrics & Gynecology
- 5.8. Market Attractiveness Analysis: Therapeutic Area
- 5.9. Global Clinical Trial Imaging Market Outlook: End User
- 5.9.1. Introduction / Key Findings
- 5.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By End User, 2019-2024
- 5.9.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
- 5.9.3.1. Contract Research Organizations (CROs)
- 5.9.3.2. Pharmaceutical & Biotechnology Companies
- 5.9.3.3. Academic and Government Research Institutes
6. Global Clinical Trial Imaging Market Outlook: Region
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
- 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
- 6.4. Market Attractiveness Analysis: Region
7. North America Clinical Trial Imaging Market Outlook:
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product & Services
- 7.2.3. By Modality
- 7.2.4. By Therapeutic Area
- 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
- 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
- 7.4.1. Services
- 7.4.2. Software
- 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
- 7.5.1. CT scan
- 7.5.2. MRI
- 7.5.3. X-Ray
- 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
- 7.6.1. Oncology
- 7.6.2. Neurology
- 7.6.3. Cardiology
- 7.6.4. Orthopedics
- 7.6.5. Obstetrics & Gynecology
- 7.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
- 7.7.1. Contract Research Organizations (CROs)
- 7.7.2. Pharmaceutical & Biotechnology Companies
- 7.7.3. Academic and Government Research Institutes
- 7.8. Market Attractiveness Analysis
8. Europe Clinical Trial Imaging Market Outlook:
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product & Services
- 8.2.3. By Modality
- 8.2.4. By Therapeutic Area
- 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
- 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
- 8.4.1. Services
- 8.4.2. Software
- 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
- 8.5.1. CT scan
- 8.5.2. MRI
- 8.5.3. X-Ray
- 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
- 8.6.1. Oncology
- 8.6.2. Neurology
- 8.6.3. Cardiology
- 8.6.4. Orthopedics
- 8.6.5. Obstetrics & Gynecology
- 8.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
- 8.7.1. Contract Research Organizations (CROs)
- 8.7.2. Pharmaceutical & Biotechnology Companies
- 8.7.3. Academic and Government Research Institutes
- 8.8. Market Attractiveness Analysis
9. East Asia Clinical Trial Imaging Market Outlook:
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product & Services
- 9.2.3. By Modality
- 9.2.4. By Therapeutic Area
- 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
- 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
- 9.4.1. Services
- 9.4.2. Software
- 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
- 9.5.1. CT scan
- 9.5.2. MRI
- 9.5.3. X-Ray
- 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
- 9.6.1. Oncology
- 9.6.2. Neurology
- 9.6.3. Cardiology
- 9.6.4. Orthopedics
- 9.6.5. Obstetrics & Gynecology
- 9.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
- 9.7.1. Contract Research Organizations (CROs)
- 9.7.2. Pharmaceutical & Biotechnology Companies
- 9.7.3. Academic and Government Research Institutes
- 9.8. Market Attractiveness Analysis
10. South Asia & Oceania Clinical Trial Imaging Market Outlook:
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product & Services
- 10.2.3. By Modality
- 10.2.4. By Therapeutic Area
- 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
- 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
- 10.4.1. Services
- 10.4.2. Software
- 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
- 10.5.1. CT scan
- 10.5.2. MRI
- 10.5.3. X-Ray
- 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
- 10.6.1. Oncology
- 10.6.2. Neurology
- 10.6.3. Cardiology
- 10.6.4. Orthopedics
- 10.6.5. Obstetrics & Gynecology
- 10.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
- 10.7.1. Contract Research Organizations (CROs)
- 10.7.2. Pharmaceutical & Biotechnology Companies
- 10.7.3. Academic and Government Research Institutes
- 10.8. Market Attractiveness Analysis
11. Latin America Clinical Trial Imaging Market Outlook:
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product & Services
- 11.2.3. By Modality
- 11.2.4. By Therapeutic Area
- 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
- 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
- 11.4.1. Services
- 11.4.2. Software
- 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
- 11.5.1. CT scan
- 11.5.2. MRI
- 11.5.3. X-Ray
- 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
- 11.6.1. Oncology
- 11.6.2. Neurology
- 11.6.3. Cardiology
- 11.6.4. Orthopedics
- 11.6.5. Obstetrics & Gynecology
- 11.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
- 11.7.1. Contract Research Organizations (CROs)
- 11.7.2. Pharmaceutical & Biotechnology Companies
- 11.7.3. Academic and Government Research Institutes
- 11.8. Market Attractiveness Analysis
12. Middle East & Africa Clinical Trial Imaging Market Outlook:
- 12.1. Key Highlights
- 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Product & Services
- 12.2.3. By Modality
- 12.2.4. By Therapeutic Area
- 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
- 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
- 12.4.1. Services
- 12.4.2. Software
- 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
- 12.5.1. CT scan
- 12.5.2. MRI
- 12.5.3. X-Ray
- 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
- 12.6.1. Oncology
- 12.6.2. Neurology
- 12.6.3. Cardiology
- 12.6.4. Orthopedics
- 12.6.5. Obstetrics & Gynecology
- 12.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
- 12.7.1. Contract Research Organizations (CROs)
- 12.7.2. Pharmaceutical & Biotechnology Companies
- 12.7.3. Academic and Government Research Institutes
- 12.8. Market Attractiveness Analysis
13. Competition Landscape
- 13.1. Market Share Analysis, 2025
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Ixico PLC
- 13.3.1.1. Overview
- 13.3.1.2. Segments and Product & Services Types
- 13.3.1.3. Key Financials
- 13.3.1.4. Market Developments
- 13.3.1.5. Market Strategy
- 13.3.2. Navitas Life Sciences
- 13.3.3. Resonance Health
- 13.3.4. Radiant Sage LLC
- 13.3.5. Medpace
- 13.3.6. WCG Clinical
- 13.3.7. Icon PLC
- 13.3.8. Voiant
- 13.3.9. Clario
- 13.3.10. Parexel International Corporation
- 13.3.11. Anagram
- 13.3.12. Calyx
- 13.3.13. Invicro
- 13.3.1. Ixico PLC
14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
